Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study
Backgrounds/Purpose The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy. Methods The 443 patients who underwent PD from April 2006 to December...
Gespeichert in:
Veröffentlicht in: | Journal of hepato-biliary-pancreatic sciences 2022-11, Vol.29 (11), p.1204-1213 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1213 |
---|---|
container_issue | 11 |
container_start_page | 1204 |
container_title | Journal of hepato-biliary-pancreatic sciences |
container_volume | 29 |
creator | Yamaki, So Satoi, Sohei Yamamoto, Tomohisa Hashimoto, Daisuke Hirooka, Satoshi Sakaguchi, Tatsuma Masuda, Masataka Shimatani, Masaaki Ikeura, Tsukasa Sekimoto, Mitsugu |
description | Backgrounds/Purpose
The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy.
Methods
The 443 patients who underwent PD from April 2006 to December 2015 were analyzed. Clinical characteristics were compared between patients with and without clinical HJ stenosis, and risk factors for clinical HJ stenosis were analyzed. In addition, the treatment and clinical course of patients with clinical HJ stenosis were retrospectively reviewed.
Results
Clinical HJ stenosis defined with intrahepatic bile duct dilatation was identified in 40 patients (9.0%). Multivariate analysis revealed that the independent risk factor for clinical HJ stenosis was the hepatic duct at surgery ≤8 mm. Endoscopic HJ stenosis was identified in 36 patients, and 31 patients were treated successfully with double balloon endoscopic retrograde cholangiography; five patients required re‐anastomosis (n = 3) and percutaneous transhepatic biliary drainage (n = 2). Complete obstruction of HJ was found in five patients, and treatment with DB‐ERC was successful in only one patient.
Conclusion
The independent risk factor for clinical HJ stenosis was hepatic duct diameter ≤8 mm. Most cases of endoscopic HJ stenosis were treated successfully with DB‐ERC, except in patients with complete obstruction.
Yamaki et al. identified clinical hepaticojejunostomy stenosis in 9.0% of cases after pancreaticoduodenectomy. The independent risk factor was a hepatic duct diameter ≤8 mm at surgery. Most cases of endoscopic hepaticojejunostomy stenosis were successfully treated with double‐balloon endoscopic retrograde cholangiography, except those with complete obstruction which required further invasive procedures. |
doi_str_mv | 10.1002/jhbp.1095 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2608535109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2608535109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3775-6d09563147312168c1c0bd2fee1fb82a5f33462bf8a3749c0f07d4772e02945b3</originalsourceid><addsrcrecordid>eNp1kU2O1DAQhS0EYkbNLLgAssQGFs34J4kddsMIGNBIIATryLHLtEPaDrbDKDuOwGE4ESfBoZtZIOGNS6XPr8rvIfSQkmeUEHY-7PqpVG19B51S2cht00p297YW1Qk6S2kg5XDKW07uoxNeScla2Zyinx9c-oKt0jnEhJU3OEdQeQ8-45SjyvB5wTZErEfnnVYj3sGkstPh1_cfAwyzDymH_VJgKKVL2IB1Hgy-cXmHnS8axxe4dyNgM-uMjRtVLr3gsbIZIp6U1-vcomvmYMCDXlWf4wscIceQptJw36CMmc3yAN2zakxwdrw36NOrlx8vr7bX716_uby43mouRL1tTHGl4bQSnDLaSE016Q2zANT2kqnacl41rLdScVG1mlgiTCUEA8Laqu75Bj056E4xfJ0h5W7vkoZxVB7CnDrWEFnzuphf0Mf_oEOYoy_bdUzUnDWiLWts0NMDpcuXUgTbTdHtVVw6Sro1zW5Ns1vTLOyjo-Lc78Hckn-zK8D5Abgpvi7_V-reXr14_0fyN9ourwM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2753267947</pqid></control><display><type>article</type><title>Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yamaki, So ; Satoi, Sohei ; Yamamoto, Tomohisa ; Hashimoto, Daisuke ; Hirooka, Satoshi ; Sakaguchi, Tatsuma ; Masuda, Masataka ; Shimatani, Masaaki ; Ikeura, Tsukasa ; Sekimoto, Mitsugu</creator><creatorcontrib>Yamaki, So ; Satoi, Sohei ; Yamamoto, Tomohisa ; Hashimoto, Daisuke ; Hirooka, Satoshi ; Sakaguchi, Tatsuma ; Masuda, Masataka ; Shimatani, Masaaki ; Ikeura, Tsukasa ; Sekimoto, Mitsugu</creatorcontrib><description>Backgrounds/Purpose
The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy.
Methods
The 443 patients who underwent PD from April 2006 to December 2015 were analyzed. Clinical characteristics were compared between patients with and without clinical HJ stenosis, and risk factors for clinical HJ stenosis were analyzed. In addition, the treatment and clinical course of patients with clinical HJ stenosis were retrospectively reviewed.
Results
Clinical HJ stenosis defined with intrahepatic bile duct dilatation was identified in 40 patients (9.0%). Multivariate analysis revealed that the independent risk factor for clinical HJ stenosis was the hepatic duct at surgery ≤8 mm. Endoscopic HJ stenosis was identified in 36 patients, and 31 patients were treated successfully with double balloon endoscopic retrograde cholangiography; five patients required re‐anastomosis (n = 3) and percutaneous transhepatic biliary drainage (n = 2). Complete obstruction of HJ was found in five patients, and treatment with DB‐ERC was successful in only one patient.
Conclusion
The independent risk factor for clinical HJ stenosis was hepatic duct diameter ≤8 mm. Most cases of endoscopic HJ stenosis were treated successfully with DB‐ERC, except in patients with complete obstruction.
Yamaki et al. identified clinical hepaticojejunostomy stenosis in 9.0% of cases after pancreaticoduodenectomy. The independent risk factor was a hepatic duct diameter ≤8 mm at surgery. Most cases of endoscopic hepaticojejunostomy stenosis were successfully treated with double‐balloon endoscopic retrograde cholangiography, except those with complete obstruction which required further invasive procedures.</description><identifier>ISSN: 1868-6974</identifier><identifier>EISSN: 1868-6982</identifier><identifier>DOI: 10.1002/jhbp.1095</identifier><identifier>PMID: 34882986</identifier><language>eng</language><publisher>Japan: Wiley Subscription Services, Inc</publisher><subject>Bile ducts ; double balloon endoscopic retrograde cholangiography ; Endoscopy ; hepatico‐jejunostomy stenosis ; intrahepatic bile duct dilatation ; Ostomy ; Pancreaticoduodenectomy ; risk factor ; Risk factors</subject><ispartof>Journal of hepato-biliary-pancreatic sciences, 2022-11, Vol.29 (11), p.1204-1213</ispartof><rights>2021 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery</rights><rights>2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.</rights><rights>Copyright © 2022 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3775-6d09563147312168c1c0bd2fee1fb82a5f33462bf8a3749c0f07d4772e02945b3</citedby><cites>FETCH-LOGICAL-c3775-6d09563147312168c1c0bd2fee1fb82a5f33462bf8a3749c0f07d4772e02945b3</cites><orcidid>0000-0001-6527-5409 ; 0000-0001-6178-7984 ; 0000-0002-7880-889X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjhbp.1095$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjhbp.1095$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34882986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamaki, So</creatorcontrib><creatorcontrib>Satoi, Sohei</creatorcontrib><creatorcontrib>Yamamoto, Tomohisa</creatorcontrib><creatorcontrib>Hashimoto, Daisuke</creatorcontrib><creatorcontrib>Hirooka, Satoshi</creatorcontrib><creatorcontrib>Sakaguchi, Tatsuma</creatorcontrib><creatorcontrib>Masuda, Masataka</creatorcontrib><creatorcontrib>Shimatani, Masaaki</creatorcontrib><creatorcontrib>Ikeura, Tsukasa</creatorcontrib><creatorcontrib>Sekimoto, Mitsugu</creatorcontrib><title>Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study</title><title>Journal of hepato-biliary-pancreatic sciences</title><addtitle>J Hepatobiliary Pancreat Sci</addtitle><description>Backgrounds/Purpose
The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy.
Methods
The 443 patients who underwent PD from April 2006 to December 2015 were analyzed. Clinical characteristics were compared between patients with and without clinical HJ stenosis, and risk factors for clinical HJ stenosis were analyzed. In addition, the treatment and clinical course of patients with clinical HJ stenosis were retrospectively reviewed.
Results
Clinical HJ stenosis defined with intrahepatic bile duct dilatation was identified in 40 patients (9.0%). Multivariate analysis revealed that the independent risk factor for clinical HJ stenosis was the hepatic duct at surgery ≤8 mm. Endoscopic HJ stenosis was identified in 36 patients, and 31 patients were treated successfully with double balloon endoscopic retrograde cholangiography; five patients required re‐anastomosis (n = 3) and percutaneous transhepatic biliary drainage (n = 2). Complete obstruction of HJ was found in five patients, and treatment with DB‐ERC was successful in only one patient.
Conclusion
The independent risk factor for clinical HJ stenosis was hepatic duct diameter ≤8 mm. Most cases of endoscopic HJ stenosis were treated successfully with DB‐ERC, except in patients with complete obstruction.
Yamaki et al. identified clinical hepaticojejunostomy stenosis in 9.0% of cases after pancreaticoduodenectomy. The independent risk factor was a hepatic duct diameter ≤8 mm at surgery. Most cases of endoscopic hepaticojejunostomy stenosis were successfully treated with double‐balloon endoscopic retrograde cholangiography, except those with complete obstruction which required further invasive procedures.</description><subject>Bile ducts</subject><subject>double balloon endoscopic retrograde cholangiography</subject><subject>Endoscopy</subject><subject>hepatico‐jejunostomy stenosis</subject><subject>intrahepatic bile duct dilatation</subject><subject>Ostomy</subject><subject>Pancreaticoduodenectomy</subject><subject>risk factor</subject><subject>Risk factors</subject><issn>1868-6974</issn><issn>1868-6982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kU2O1DAQhS0EYkbNLLgAssQGFs34J4kddsMIGNBIIATryLHLtEPaDrbDKDuOwGE4ESfBoZtZIOGNS6XPr8rvIfSQkmeUEHY-7PqpVG19B51S2cht00p297YW1Qk6S2kg5XDKW07uoxNeScla2Zyinx9c-oKt0jnEhJU3OEdQeQ8-45SjyvB5wTZErEfnnVYj3sGkstPh1_cfAwyzDymH_VJgKKVL2IB1Hgy-cXmHnS8axxe4dyNgM-uMjRtVLr3gsbIZIp6U1-vcomvmYMCDXlWf4wscIceQptJw36CMmc3yAN2zakxwdrw36NOrlx8vr7bX716_uby43mouRL1tTHGl4bQSnDLaSE016Q2zANT2kqnacl41rLdScVG1mlgiTCUEA8Laqu75Bj056E4xfJ0h5W7vkoZxVB7CnDrWEFnzuphf0Mf_oEOYoy_bdUzUnDWiLWts0NMDpcuXUgTbTdHtVVw6Sro1zW5Ns1vTLOyjo-Lc78Hckn-zK8D5Abgpvi7_V-reXr14_0fyN9ourwM</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Yamaki, So</creator><creator>Satoi, Sohei</creator><creator>Yamamoto, Tomohisa</creator><creator>Hashimoto, Daisuke</creator><creator>Hirooka, Satoshi</creator><creator>Sakaguchi, Tatsuma</creator><creator>Masuda, Masataka</creator><creator>Shimatani, Masaaki</creator><creator>Ikeura, Tsukasa</creator><creator>Sekimoto, Mitsugu</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6527-5409</orcidid><orcidid>https://orcid.org/0000-0001-6178-7984</orcidid><orcidid>https://orcid.org/0000-0002-7880-889X</orcidid></search><sort><creationdate>202211</creationdate><title>Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study</title><author>Yamaki, So ; Satoi, Sohei ; Yamamoto, Tomohisa ; Hashimoto, Daisuke ; Hirooka, Satoshi ; Sakaguchi, Tatsuma ; Masuda, Masataka ; Shimatani, Masaaki ; Ikeura, Tsukasa ; Sekimoto, Mitsugu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3775-6d09563147312168c1c0bd2fee1fb82a5f33462bf8a3749c0f07d4772e02945b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bile ducts</topic><topic>double balloon endoscopic retrograde cholangiography</topic><topic>Endoscopy</topic><topic>hepatico‐jejunostomy stenosis</topic><topic>intrahepatic bile duct dilatation</topic><topic>Ostomy</topic><topic>Pancreaticoduodenectomy</topic><topic>risk factor</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamaki, So</creatorcontrib><creatorcontrib>Satoi, Sohei</creatorcontrib><creatorcontrib>Yamamoto, Tomohisa</creatorcontrib><creatorcontrib>Hashimoto, Daisuke</creatorcontrib><creatorcontrib>Hirooka, Satoshi</creatorcontrib><creatorcontrib>Sakaguchi, Tatsuma</creatorcontrib><creatorcontrib>Masuda, Masataka</creatorcontrib><creatorcontrib>Shimatani, Masaaki</creatorcontrib><creatorcontrib>Ikeura, Tsukasa</creatorcontrib><creatorcontrib>Sekimoto, Mitsugu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepato-biliary-pancreatic sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaki, So</au><au>Satoi, Sohei</au><au>Yamamoto, Tomohisa</au><au>Hashimoto, Daisuke</au><au>Hirooka, Satoshi</au><au>Sakaguchi, Tatsuma</au><au>Masuda, Masataka</au><au>Shimatani, Masaaki</au><au>Ikeura, Tsukasa</au><au>Sekimoto, Mitsugu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study</atitle><jtitle>Journal of hepato-biliary-pancreatic sciences</jtitle><addtitle>J Hepatobiliary Pancreat Sci</addtitle><date>2022-11</date><risdate>2022</risdate><volume>29</volume><issue>11</issue><spage>1204</spage><epage>1213</epage><pages>1204-1213</pages><issn>1868-6974</issn><eissn>1868-6982</eissn><abstract>Backgrounds/Purpose
The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy.
Methods
The 443 patients who underwent PD from April 2006 to December 2015 were analyzed. Clinical characteristics were compared between patients with and without clinical HJ stenosis, and risk factors for clinical HJ stenosis were analyzed. In addition, the treatment and clinical course of patients with clinical HJ stenosis were retrospectively reviewed.
Results
Clinical HJ stenosis defined with intrahepatic bile duct dilatation was identified in 40 patients (9.0%). Multivariate analysis revealed that the independent risk factor for clinical HJ stenosis was the hepatic duct at surgery ≤8 mm. Endoscopic HJ stenosis was identified in 36 patients, and 31 patients were treated successfully with double balloon endoscopic retrograde cholangiography; five patients required re‐anastomosis (n = 3) and percutaneous transhepatic biliary drainage (n = 2). Complete obstruction of HJ was found in five patients, and treatment with DB‐ERC was successful in only one patient.
Conclusion
The independent risk factor for clinical HJ stenosis was hepatic duct diameter ≤8 mm. Most cases of endoscopic HJ stenosis were treated successfully with DB‐ERC, except in patients with complete obstruction.
Yamaki et al. identified clinical hepaticojejunostomy stenosis in 9.0% of cases after pancreaticoduodenectomy. The independent risk factor was a hepatic duct diameter ≤8 mm at surgery. Most cases of endoscopic hepaticojejunostomy stenosis were successfully treated with double‐balloon endoscopic retrograde cholangiography, except those with complete obstruction which required further invasive procedures.</abstract><cop>Japan</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34882986</pmid><doi>10.1002/jhbp.1095</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-6527-5409</orcidid><orcidid>https://orcid.org/0000-0001-6178-7984</orcidid><orcidid>https://orcid.org/0000-0002-7880-889X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1868-6974 |
ispartof | Journal of hepato-biliary-pancreatic sciences, 2022-11, Vol.29 (11), p.1204-1213 |
issn | 1868-6974 1868-6982 |
language | eng |
recordid | cdi_proquest_miscellaneous_2608535109 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | Bile ducts double balloon endoscopic retrograde cholangiography Endoscopy hepatico‐jejunostomy stenosis intrahepatic bile duct dilatation Ostomy Pancreaticoduodenectomy risk factor Risk factors |
title | Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T23%3A49%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20and%20treatment%20strategy%20for%20clinical%20hepatico%E2%80%90jejunostomy%20stenosis%20defined%20with%20intrahepatic%20bile%20duct%20dilatation%20after%20pancreaticoduodenectomy:%20A%20retrospective%20study&rft.jtitle=Journal%20of%20hepato-biliary-pancreatic%20sciences&rft.au=Yamaki,%20So&rft.date=2022-11&rft.volume=29&rft.issue=11&rft.spage=1204&rft.epage=1213&rft.pages=1204-1213&rft.issn=1868-6974&rft.eissn=1868-6982&rft_id=info:doi/10.1002/jhbp.1095&rft_dat=%3Cproquest_cross%3E2608535109%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2753267947&rft_id=info:pmid/34882986&rfr_iscdi=true |